AKBA
NASDAQ · Biotechnology
Akebia Therapeutics Inc
$1.16
-0.02 (-1.69%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,128.4% upside
Low Target
$22.27
Average Target
$37.45
High Target
$46.32
Current Price
$1.16
Current
$1.16
$1.16
Target
$37.45
$37.45
$22.27
$37.45 avg
$46.32
Scenario Analysis
Bear Case
$22.27
1,819.8%
Low target
Base Case
$37.45
+3,128.4%
Avg target
Bull Case
$46.32
+3,893.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$4.08
-71.6% from high
52-Week Low
$1.13
+2.7% from low
Target vs 52W High
$37.45
+818.2% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.03
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |